P058. Refractory chronic migraine, fatigue and OnabotulinumtoxinA: a clinic setting experience

被引：0
|
作者：
Filippo Baldacci
Martina Cafalli
Cinzia Lucchesi
Sonia Mazzucchi
Elisa Dini
Ubaldo Bonuccelli
Sara Gori
机构：
[1] University of Pisa,Neurology Unit, Department of Clinical and Experimental Medicine
来源：
The Journal of Headache and Pain | 2015年 / 16卷
关键词：
Migraine; Anxiety Disorder; Generalize Anxiety Disorder; Chronic Migraine; Patient Health Questionnaire;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] P054. Chronic migraine and onabotulinumtoxinA: results from clinical practice
    Matteo Paolucci
    Riccardo Altavilla
    Giulia Gambale
    Claudio Altamura
    Giovanna Viticchi
    Marco Bartolini
    Mauro Silvestrini
    Fabrizio Vernieri
    The Journal of Headache and Pain, 2015, 16
  • [32] OnabotulinumtoxinA for the prevention of chronic migraine in adolescents: the experience of an italian third level headache center
    Frattale, I.
    Ursitti, F.
    Sforza, G.
    Monte, G.
    Ferilli, M. A. N.
    Tarantino, S.
    Checchi, M. Proietti
    Valeriani, M.
    Papetti, L.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [33] OnabotulinumtoxinA for the prevention of chronic migraine in adolescents: the experience of an italian third level headache center
    Frattale, Ilaria
    Papetti, Laura
    Ursitti, Fabiana
    Sforza, Giorgia
    Monte, Gabriele
    Ferilli, Michela Ada Noris
    Tarantino, Samuela
    Checchi, Martina Proietti
    Valeriani, Massimiliano
    CEPHALALGIA, 2023, 43 (1supp) : 140 - 141
  • [34] LONG TERM OUTCOME FOR ONABOTULINUMTOXINA IN CHRONIC MIGRAINE; TWO YEAR FOLLOW UP OF 302 PATIENTS FROM THE HULL MIGRAINE CLINIC
    Buture, A.
    Nimeri, R.
    Khalil, M.
    Ahmed, F.
    CEPHALALGIA, 2016, 36 : 16 - 17
  • [35] Cognitive Behavioral Therapy Experience in Patients With Refractory Chronic Migraine
    Uluduz, Derya
    Ertem, Devrimsel H.
    Onur, Ozge S.
    Ozge, Aynur
    Karsidag, Cagatay
    Siva, Aksel
    CEPHALALGIA, 2017, 37 : 335 - 335
  • [36] P045. OnabotulinumtoxinA: long term treatment for chronic migraine with medication overuse
    Simona Guerzoni
    Maria Michela Cainazzo
    Luigi Alberto Pini
    The Journal of Headache and Pain, 2015, 16
  • [37] OnabotulinumtoxinA add-on to monoclonal anti-CGRP antibodies in treatment-refractory chronic migraine
    Dermitzakis, E.
    Argyriou, A.
    Xiromerisiou, G.
    Vikelis, M.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [38] OnabotulinumtoxinA Add-On to Monoclonal Anti-CGRP Antibodies in Treatment-Refractory Chronic Migraine
    Argyriou, Andreas A. A.
    Dermitzakis, Emmanouil V. V.
    Xiromerisiou, Georgia
    Vikelis, Michail
    TOXINS, 2022, 14 (12)
  • [39] When chronic migraine remains refractory: can anti-CGRP monoclonal antibodies be combined with onabotulinumtoxinA?
    Martins Silva, E.
    Pereira, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 611 - 611
  • [40] Long term outcome for OnabotulinumtoxinA therapy in Chronic Migraine; a two year follow up of 403 patients from the Hull Migraine Clinic
    Buture, Alina
    Ghabeli, Ali J.
    Khalil, Modar
    Ahmed, Fayyaz
    CEPHALALGIA, 2017, 37 : 113 - 113
12345